PDT Partners LLC purchased a new position in shares of PACS Group, Inc. (NYSE:PACS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 125,729 shares of the company's stock, valued at approximately $1,648,000. PDT Partners LLC owned about 0.08% of PACS Group as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Schonfeld Strategic Advisors LLC raised its stake in shares of PACS Group by 36.7% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 162,666 shares of the company's stock worth $2,133,000 after purchasing an additional 43,632 shares during the last quarter. Northern Trust Corp lifted its position in PACS Group by 3.6% in the fourth quarter. Northern Trust Corp now owns 332,908 shares of the company's stock valued at $4,364,000 after purchasing an additional 11,430 shares during the period. Tudor Investment Corp ET AL boosted its holdings in PACS Group by 540.2% in the 4th quarter. Tudor Investment Corp ET AL now owns 274,804 shares of the company's stock valued at $3,603,000 after purchasing an additional 231,882 shares in the last quarter. Oxford Asset Management LLP acquired a new position in PACS Group during the 4th quarter worth approximately $205,000. Finally, Price T Rowe Associates Inc. MD lifted its holdings in shares of PACS Group by 20.1% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,524 shares of the company's stock valued at $204,000 after buying an additional 2,598 shares during the period.
Analyst Upgrades and Downgrades
Several research firms have issued reports on PACS. Macquarie cut their price objective on PACS Group from $42.00 to $24.00 and set an "outperform" rating for the company in a research report on Monday, January 6th. Truist Financial dropped their target price on shares of PACS Group from $46.00 to $32.00 and set a "buy" rating for the company in a report on Monday, January 6th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $34.00.
View Our Latest Report on PACS Group
PACS Group Price Performance
PACS stock traded down $0.00 on Monday, reaching $10.07. The company had a trading volume of 81,243 shares, compared to its average volume of 782,570. The company's fifty day moving average is $10.79 and its 200 day moving average is $15.72. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.71 and a quick ratio of 1.71. PACS Group, Inc. has a 1 year low of $8.28 and a 1 year high of $43.92.
PACS Group Profile
(
Free Report)
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Further Reading

Before you consider PACS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PACS Group wasn't on the list.
While PACS Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.